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Targeted Overactivity of b Cell KATP Channels
Induces Profound Neonatal Diabetes
is proposed as a critical link in the pathway of glucose-
induced insulin release (Cook et al., 1988; Misler et al.,
1992). During the fed state, when intracellular glucose
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is high, inhibition of pancreatic KATP channels due to aWashington University School of Medicine
high intracellular [ATP]/[ADP] ratio is presumed to depo-St. Louis, Missouri 63110
larize the plasma membrane, leading to Ca21 entry²Department of Pediatrics
through voltage-dependent Ca21 channels. The rise inSt. Louis Children's Hospital
intracellular Ca21 then stimulates insulin release, caus-St. Louis, Missouri 63110
ing glucose uptake in peripheral tissues. Conversely, a³The Edward A. Doisy Department of Biochemistry and
falling intracellular [ATP]/[ADP] ratio during the fastingMolecular Biology
state is presumed to activate KATP channels, causingSaint Louis University School of Medicine
membrane hyperpolarization and cessation of insulinSt. Louis, Missouri 63104
release. Thus, mutations that alter the response of the
pancreatic KATP channel to intracellular [ATP]/[ADP] lev-
els are predicted to perturb this secretory process and
Summary impair glucose homeostasis.
Recently, mutations in the SUR1 and Kir6.2 subunits
A paradigm for control of insulin secretion is that glu- have been identified that are postulated to underlie fa-
cose metabolism elevates cytoplasmic [ATP]/[ADP] in milial persistent hyperinsulinemic hypoglycemia of in-
b cells, closing KATP channels and causing depolariza- fancy (PHHI) in humans. This disease is an autosomal
tion, Ca21 entry, and insulin release. Decreased re- recessive disorder characterized by constitutive insulin
sponsiveness of KATP channels to elevated [ATP]/[ADP] secretion despite severe, prolonged fasting hypoglyce-
should therefore lead to decreased insulin secretion mia. When expressed in vitro, reconstituted mutant KATP
and diabetes. To test this critical prediction, we gen- channels are nonfunctional or exhibit a reduced re-
erated transgenic mice expressing b cell KATP chan- sponse to a fall in the [ATP]/[ADP] ratio (Nichols et al.,
nels with reduced ATP sensitivity. Animals develop 1996; Nestorowicz et al., 1997; Shyng et al., 1998). In
severe hyperglycemia, hypoinsulinemia, and ketoaci- the pancreatic b cell, such impaired KATP channel activity
dosis within 2 days and typically die within 5. Neverthe- is expected to result in a constitutively depolarized state
less, islet morphology, insulin localization, and a and and unregulated insulin secretion. Therefore, the KATP
b cell distributions were normal (before day 3), pointing mutations identified can account for the hyperinsulin-
to reduced insulin secretion as causal. The data indi- emia and hypoglycemia observed in these PHHI pa-
cate that normal KATP channel activity is critical for tients. Consistent with this model, reduction of KATP
channel activity in mouse pancreatic b cells, by overex-maintenance of euglycemia and that overactivity can
pression of a dominant-negative Kir6.2, recapitulates acause diabetes by inhibiting insulin secretion.
weak PHHI-like phenotype (Miki et al., 1997), in which
neonatal transgenic mice develop hypoglycemia withIntroduction
hyperinsulinemia and display elevated basal calcium
levels in the b cells. Interestingly, transgenic mice sur-ATP-sensitive K1 channels (KATP) are complexes of two
vive to adulthood but become hyperglycemic with hypo-distinct subunits, a sulfonylurea receptor (SURx) and a
insulinemia as a consequence of extensive b cell apo-pore-forming Kir6.x subunit, a member of the inward
ptosis (Miki et al., 1997).rectifier K1 channel family (Inagaki et al., 1995, 1997;
In contrast to loss-of-function mutations associatedClement et al., 1997). The regulatory SUR1 subunit con-
with familial hyperinsulinism, mutations in KATP that re-fers high-affinity block by sulfonylureas and stimulation
duce sensitivity to inhibitory [ATP]/[ADP] (i.e., gain ofby K1 channel openers and MgADP (potassium channel
function mutations) are predicted to give rise to theopeners [PCOs]) on pancreatic KATP channels (Aguilar- corollary disease, diabetes mellitus. This important hy-Bryan et al., 1995; Inagaki et al., 1996; Isomoto et al.,
pothesis has not been tested, despite the fact that nu-1996; Nichols et al., 1996; Gribble et al., 1997a, 1997b;
merous mutations that significantly reduce ATP sensitiv-
Shyng et al., 1997a; Schwanstecher et al., 1998). ATP
ity of reconstituted KATP channels have been introducedinhibits channel activity through an interaction with the
into the Kir6.2 subunit (Tucker et al., 1997, 1998; Drain
Kir6.2 subunit (Shyng et al., 1997b; Tucker et al., 1997, et al., 1998; Koster et al., 1999a; Proks et al., 1999).
1998; Tanabe et al., 1999). The unique dependence of To this end, we have generated transgenic mice that
channel activity on intracellular nucleotides underlies specifically express KATP channels with reduced ATPthe physiologic role of the KATP channel by coupling the sensitivity in the pancreatic b cells. Consistent with the
metabolic status of a cell to electrical activity (reviewed proposed model of glucose-induced insulin release,
in Ashcroft, 1988). In pancreatic b cells, the KATP channel transgenic mice expressing such mutant KATP channels
develop severe diabetes characterized by hyperglyce-
mia with hypoinsulinemia and ketoacidosis, but with§ To whom correspondence should be addressed (e-mail: cnichols@
normal a and b cell populations. The data implicatecellbio.wustl.edu).
k These authors contributed equally to this work. overactive KATP channels in early-onset diabetes mellitus
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Figure 1. Transgenic Kir6.2 Channel Con-
structs and Transgenic Mouse Phenotype
(A) Schematic of the Kir6.2 subunit illustrating
the region in the N terminus that was deleted
to generate the Kir6.2[DN2-30] truncated sub-
unit. The green fluorescent protein (GFP) was
fused to the C termini of Kir6.2 to allow detec-
tion under UV illumination. The Kir6.2 subunit
contains two transmembrane segments, M1
and M2, a pore-forming H5 segment, and cy-
toplasmic N and C termini.
(B) Steady-state dependence of membrane
current on [ATP] (mean 6 SEM, relative to cur-
rent in zero ATP [Irel]) for wild-type and mutant
channels coexpressed with SUR1 in COSm6
cells. Data points represent the mean 6
SEM (n 5 3±8 patches). The fitted lines
correspond to least squares fits of the Hill
equation (relative current 5 100/(1 1 ([ATP]/
Ki )H), with H fixed at 1.3, and Ki 5 12
mM (Kir6.2 1SUR1, dashed), 123.8 mM
(Kir6.2[DN2-30] 1 SUR1, dashed), 107 mM
(Kir6.2[DN2-30]-GFP 1 SUR1), and 4200
mM (Kir6.2[DN2-30,K185Q]-GFP 1 SUR1).
(C) Blood glucose levels in neonatal (day 2±4)
control, Kir6.2[DN2-30] transgenic (lines A, B,
and E), and Kir6.2[AAA] transgenic mice. Indi-
vidual values and mean 6 SEM are indicated.
Values above the upper detection limit of 400
mg/dl are shown in shaded area.
(D) Serum insulin levels in neonatal (day 2±4) control, Kir6.2[DN2-30] transgenic (lines A, B, and E), and Kir6.2[AAA] transgenic mice. Individual
values and mean 6 SEM are indicated. The shaded area represents the lower detection limit of the assay. For Kir6.2[DN2-30] transgenics,
four of eight neonates had estimated insulin levels below the detection limit of 156 pg/ml.
(E) Blood ketone levels (D-3-hydroxybutyrate, mean 6 SEM) in Kir6.2[DN2-30] transgenic mice (line A; n 5 4) and control mice (n 5 8) in
neonate mice (day 2).
in these mice and indicate the critical role of normal KATP mM, and 4 mM for wild-type Kir6.2 1 SUR1, Kir6.2[DN2-
30]-GFP 1 SUR1, and Kir6.2[DN2-30,K185Q]-GFP 1channel activity in the physiological control of insulin
secretion. SUR1 channels, respectively).
KATP channels are expressed in many excitable tissues.
To specifically study the effects of manipulation of KATP
Results channels in islet b cells, we generated transgenic mice
expressing mutant Kir6.2 minigenes under control of the
Creation of b Cell±Targeted Kir6.2 Transgenes rat insulin promoter I (Dandoy-Dron et al., 1991). PCR
Normal pancreatic KATP channels have a high sensitivity analysis of isolated mouse-tail DNA identified no found-
to inhibitory ATP, with Ki ([ATP] causing half-maximal ers for the Kir6.2[DN2-30,K185Q] transgene out of 60
inhibition) z10 mM in excised patches (Ashcroft, 1988). potential founder mice. Five mice typing positive for
Truncation of the N-terminal 30 amino acids of the Kir6.2 the Kir6.2[DN2-30] transgene were identified out of 32
subunit results in KATP channels with z10-fold lower ATP potential founders. These mice were bred with the
sensitivity and reduced high-affinity sulfonylurea sensi- CD-1 strain to establish five Kir6.2[DN2-30] transgenic
tivity (Babenko et al., 1999; Koster et al., 1999a, 1999b; lines, designated A, B, C, D, and E (Table 1). An addi-
Reimann et al., 1999). This deletion, in combination with tional minigene was created containing Kir6.2[AAA]-
a point mutation (K185Q), results in a further z30-fold GFP, in which residues G156, F157, and G158 were each
reduction of ATP sensitivity (Koster et al., 1999a). For substituted by alanine residues. A similar Kir6.2[AFA]
the present study, the N-terminal truncated subunit, construct has previously been shown to dominant-nega-
Kir6.2[DN2-30] (Figure 1A), and the double mutant tively suppress KATP channel currents, in transfected
(Kir6.2[DN2-30,K185Q]) were fused at the C terminus cells, and in transgenic animals (Miki et al., 1997; Lalli
with the green fluorescent protein (GFP) to allow for et al., 1998). One founder mouse was identified and
detection under UV illumination. In coexpression with bred with the CD-1 strain to establish a Kir6.2[AAA]
SUR1 in transfected COSm6 cells, addition of the GFP transgenic line.
tag to recombinant KATP channels did not significantly
alter [ATP] sensitivity (Figure 1B) or single channel con-
ductance (data not shown). Consistent with our previous Overactive KATP Channels Cause a Severe
Diabetic Phenotypereport, reconstituted Kir6.2[DN2-30]-GFP 1 SUR1 and
Kir6.2[DN2-30,K185Q]-GFP 1 SUR1 channels were, re- All Kir6.2[DN2-30] founder mice were euglycemic, devel-
oped apparently normally, and were fertile. However, allspectively, z7-fold and z250-fold less sensitive to inhi-
bition by ATP than wild-type channels (Ki 5 16 mM, 107 transgenic F1 progeny from lines A, B, C, and E, but not
Diabetes Caused by KATP Channel Overactivity
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Table 1. Survivability of Kir6.2[DN2-30] Transgenic Lines
Copies Percent Transgenicb Transmission
Line Sex Kir6.2-GFP Pups Born Pups Weaned Day 21 (Typing Days 2-4)
A ? 2 93 44 (47%) (all wild-type) 35%
B / 3 50 22 (47%) (all wild-type) ND
C / 4 51 31 (60%) (all wild-type) ND
E ? 9 71 47 (66%) (3 Tg, 44 wild-type)a 42%
Control (C57BL/6J) ?// Ð 94 91 (97%) Ð
Survivability data were obtained in crosses of founder mice with the CD-1 mouse strain; similar data were obtained in C57BL/6J and B6SJL/
F2 crosses (data not shown). In the D line transgenic, offspring are viable and fertile in both F1 and F2 generations (data not shown).
a Of the transgenic E line mice surviving to day 21 (n 5 3, all female), one died within 3 days of being weaned, one lived three months without
treatment, and one survived 3 months on administered insulin (see Figure 2).
b Neonate mice from litters different than those used to calculate survivability were sacrificed at days 2-4 and typed for the presence of the
transgene (A line, n 5 43; E line, n 5 31; ND, not determined).
D, were severely hyperglycemic with hypoinsulinemia (Clement et al., 1997; Inagaki et al., 1997; Shyng and
Nichols, 1997). When Kir6.2 subunits are overexpressedand exhibited significantly elevated blood D-3-hydroxy-
butyrate levels (Figures 1C±1E). Among these four dia- in the transgenic b cells, SUR1 is likely to be rate limiting
for channel formation, such that the transgenic subunitsbetic transgenic lines, neonatal lethality was uniformly
observed (Table 1). Most animals died by day 5; of those will replace endogenous subunits, and a partial ªfunc-
tional knockinº of the transgenic construct will be ex-transgenic mice that survived to weaning (3 of z150
transgenic births, i.e., z2%), whole body weight was pected. To examine the activity of Kir6.2[DN2-30] mutant
channels in transgenic b cells, ATP-sensitive K1 cur-significantly reduced when compared to control mice
and could only be increased by administering increasing rents from pancreatic b cells were analyzed using the
inside-out patch-clamp technique. Membrane patchesdosages of insulin (Figure 2). Outbreeding founders with
other mouse strains (B6SJL, or C57BL/6J), or a mouse from both control and transgenic b cells were isolated
and then exposed to varying [ATP] (Figure 4A). As shownline exhibiting mild hypoglycemia as a consequence of
overexpressing the glucose transporter, GLUT1 (Mar- in Figure 4B, KATP channels in isolated membrane
patches from transgenic mice on average showed ashall et al., 1993), failed to alleviate the hyperglycemia
and morbidity in transgenic neonates (data not shown). shallower, and significantly reduced, sensitivity to inhibi-
tory ATP, compared to controls [Ki 5 67 6 20 mMBy contrast, transgenic mice expressing the Kir6.2[AAA]
dominant-negative construct had essentially normal (Kir6.2[DN2-30] Tg.) and 17 6 5 mM (control); P , 0.02].
The shallower mean dose-response curve (Figure 4B)blood glucose and serum insulin levels at day 3 (Figures
1C and 1D). Taken together, these data demonstrate a and the wider range of ATP sensitivities in individual
patches (Figure 4C) suggests the existence of a hetero-strong correlation between the specific expression of
the Kir6.2[DN2-30] transgene and the severe diabetic geneous population of KATP channels consisting of both
endogenous and mutant Kir6.2 subunits in transgenicstate in neonatal and adult mice.
To confirm expression of the GFP-tagged Kir6.2[DN2- b cells. Consistent with the notion that the transgenic
subunits are replacing wild-type subunits rather than30] protein, pancreatic islets were isolated from a
founder mouse (line C) carrying the Kir6.2[DN2-30] generating additional channels, maximal KATP current
density, as estimated from the averaged membranetransgene. As shown in Figure 3, b cell±specific green
fluorescence is present in b cells in islets from the patch current, was only slightly elevated in Kir6.2[DN2-
30] transgenic b cells and was substantially reducedKir6.2[DN2-30] transgenic mouse but not in islets from
the control mouse. However, by way of comparison, in Kir6.2[AAA] b cells from the Kir6.2[AAA] transgenics
there are significantly more green fluorescing cells in an (Figure 4D).
islet from an adult F1 mouse expressing the GFP-tagged
Kir6.2[AAA] construct (Figure 3E). It would appear that
Hyperglycemia Does Not Obviously Resultthe Kir6.2[DN2-30] subunit is expressed in far fewer b
from Insulin Deficiency in the Isletcells in the C line founder, even though the fluorescence
Progressive loss of the insulin-secreting cells and redis-level in the positively expressing cells is qualitatively
tribution of non-b cells from the periphery of the islet tosimilar. Functional and genetic mosaicism is common
the central region is a common characteristic of humansin transgenic founder mice (Allen et al., 1990; Engler et
and animals with insulin-dependent diabetes mellitusal., 1991; Overbeek, 1994; Dobie et al., 1996) and is
(IDDM) (Baetens et al., 1978; Rahier et al., 1983). Tolikely to account for euglycemia of the Kir6.2[DN2-30]
address the possibility that morphological abnormalitiesfounders (A, B, C, and E lines) and yet severe diabetic
of pancreatic islets could underlie the severe diabeticstate of the transgenic F1 progeny. Expression of the
state in the Kir6.2[DN2-30] mice, immunohistochemicaltransgene was also observed in islets from adult F1 mice
analyses were performed on sectioned pancreata fromfrom the D line, but very few positively fluorescing cells
neonatal mice at day 3. As shown in Figure 5, immuno-were observed in each islet (data not shown). Thus, the
staining of insulin-containing b cells from a severelylow level of transgenic expression may also explain the
diabetic transgenic pancreas reveals no obvious abnor-nondiabetic phenotype in F1 transgenic D line mice.
mality in islet size and distribution and no obvious lackKATP channels are formed as tetramers of Kir6.2 sub-
units, each of which is associated with a SUR1 subunit of insulin. This argues against the possibility that insulin
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to control islets. Only after a prolonged period of hyper-
glycemia (.3 days) was a characteristic, diabetes-
induced redistribution of a and b cells (Baetens et al.,
1978; Rahier et al., 1983) observed (Figures 6E and 6F).
There are no gross morphological changes of a or b
cell populations preceding the impairment of glucose
homeostasis in the transgenic mice.
Discussion
The KATP Channel-Dependent Pathway of Insulin
Secretion: KATP Channel Overactivity Causes
Severe Diabetes
A paradigm for glucose regulation of insulin secretion
is that b cell metabolism of glucose leads to elevated
cytoplasmic [ATP]/[ADP] ratio, which then closes KATP
channels, permitting depolarization, Ca21 entry through
depolarization-activated Ca21 channels, and release of
insulin (reviewed in Ashcroft and Rorsman, 1990). The
role of glucose metabolism and ATP synthesis in insulin
secretion is highlighted by the demonstration that inher-
ited diabetes can result from decreased activity of the
rate-limiting glycolytic enzymes (Hattersley et al., 1992;
Vionnet et al., 1992; Froguel et al., 1993; Terauchi et al.,
1995; Zhou et al., 1995; Vionnet et al., 1992; Dukes et
al., 1998; Sakura et al., 1998; Pontoglio et al., 1998).
Substantial evidence is consistent with coupling of ATP
production to insulin release via KATP channels, includ-
ing many cellular metabolism and electrophysiological
studies (Ashcroft, 1988). An important line of support
comes from examination of the genetic basis of persis-
tent hypoglycemic hyperinsulinema of infancy (PHHI), a
disease in which unregulated insulin secretion causes
precipitous lowering of blood glucose levels (Aynsley-
Green et al., 1981; Thomas et al., 1995; Nestorowicz et
al., 1996; Dunne et al., 1997; Shyng et al., 1998). These
studies have demonstrated that many, if not most, cases
result from mutations in the sulfonylurea receptor or
Kir6.2 genes. In these patients, there is no functional
Figure 2. Insulin-Dependent Growth in a Diabetic Kir6.2[DN2-30] KATP channel produced (Kane et al., 1996; NestorowiczTransgenic Mouse
et al., 1996), or channels are insensitive to a fall in [ATP]/
(A) Photograph of a surviving E line diabetic Kir6.2[DN2-30] trans-
[ADP] ratio (Nichols et al., 1996; Shyng et al., 1998) andgenic mouse (Tg) and control littermate, day 60.
do not open appropriately in order to shut off insulin(B) Averaged weight of transgenic (n 5 3 females; E line) and control
secretion.mice (n 5 32 females) at day 21; *, P , 0.0001.
(C) Insulin-dependent growth of transgenic mouse shown in (A) from A critical, and untested, prediction of the ATP-sensi-
day 33 to day 70. The insulin dose administered (open circles) and tive pathway paradigm is that KATP channels with re-
the corresponding weight of the transgenic mouse (closed circles) duced sensitivity to nucleotide inhibition should be hy-
on the day of the dosage are shown. The corresponding weight of peractive, leading to reduced insulin secretion and
a control littermate (open squares; no insulin dosage) for days 54
diabetes. Expression of the Kir6.2[DN2-30] minigene inand 59 are shown. The blood glucose level of the transgenic mouse
transgenic mice resulted in pancreatic KATP channelswas .400 mg/dl at every time point.
with reduced ATP sensitivity and b cell±specific fluores-
cence of the green fluorescent protein (GFP) tagged
deficiency underlies the hyperglycemic state, especially channel. The effects of transgenic expression were pro-
given that rats can apparently maintain near-normal gly- found and included early onset diabetes characterized
cemia with only 10% of control pancreatic insulin con- by reduced serum insulin levels and dramatically ele-
tent (Bonner-Weir et al., 1983). To further examine the vated blood glucose and ketone levels. Mortality with
possibility of islet histopathology at the earliest stage ketoacidosis among transgenic neonates was virtually
of hyperglycemia, immunofluorescence was used to lo- complete. It is significant that no founder mice were
calize glucagon containing a cells in islets from mice at generated in 60 live births from embryos injected with
1 day of age [blood glucose 5 303 mg/dl (Kir6.2[DN2- the Kir6.2[DN2-30,K185Q] minigene. This construct would
30] Tg.); and 76.2 6 3.2 mg/dl (control)]. As shown in have been expected to generate KATP channels with more
Figure 6, a cells in islets from the transgenic animal severely reduced ATP sensitivity, leading us to conclude
exhibit a typical peripheral distribution around a core of that this transgene may result in such a severe pheno-
type that animals die in utero.strongly fluorescing b cells, which is qualitatively similar
Diabetes Caused by KATP Channel Overactivity
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Figure 3. Fluorescence of GFP-Tagged KATP
Channels in Isolated Islets from Transgenic
Mice
Clear field and fluorescent images of iso-
lated islets from a control mouse (A and B),
the C line founder mouse expressing the
Kir6.2[DN2-30] transgene (C and D), and a
transgenic mouse expressing a dominant-
negative Kir6.2 subunit tagged with GFP (Kir-
6.2[AAA]) (E and F).
In contrast to the severe diabetic phenotype resulting pancreatic b cells (reviewed in Bosch et al., 1998). In a
few cases, most notably in the overexpression of cal-from overactive KATP channels, overexpression of domi-
nant-negative Kir6.2[AFA] (Miki et al., 1997) or Kir6.2[AAA] modulin (Epstein et al., 1989), severe histopathological
changes have been noted and include a marked reduc-constructs (this study), which abolish or significantly
reduce KATP channel activity in pancreatic b cells, have tion in the number and volume of the islets, a decrease
in b cell mass and insulin content, and irregular distribu-relatively minimal effects on glucose homeostasis. Trans-
genic overexpression of another K channel gene (volt- tion of non-b cells within the islets (Cesar et al., 1994).
Thus, pancreatic pathology could account for the severeage-gated K channel gene Kv1.5) in b cells (Philipson et
al., 1994) resulted in animals with a mildly hyperglycemic diabetes observed in calmodulin-overexpressing mice,
but a similar nonspecific effect of insulin promoter-phenotype, although there was no reported ketoacido-
sis or further complications. The considerably more se- driven overproduction of protein cannot explain the dia-
betic phenotype in Kir6.2[DN2-30] mice. First, immuno-vere phenotype in the Kir6.2[DN2-30] transgenic animals
further indicates the specificity of the effect of the cytochemistry reveals a normal size and distribution of
pancreatic islets in day 1 or 2 transgenic mice that al-Kir6.2[DN2-30] transgene and is consistent with a differ-
ential role of KATP channels in b cell excitability. While ready display severe hyperglycemia (blood glucose $
400 mg/dl). Second, at the early stages of hyperglycemiadelayed rectifier K channels modulate the action poten-
tials that follow glucose-induced depolarization, KATP (day 1), glucagon-containing a cells show typically pe-
ripheral distribution in the islets, and only after longerchannels critically control the threshold level of glucose
required to induce the depolarization in the first place. periods of hyperglycemia (. 3 days) is a redistribution
of the a cells observed. Third, the Kir6.2[AAA] transgene,To date, the insulin promoter has been utilized to
direct the expression of numerous proteins in mouse which is identical to the Kir6.2[DN2-30] transgene except
Cell
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Figure 4. ATP Sensitivity of Pancreatic KATP
Channels from Transgenic Mice Expressing
the Kir6.2[DN2-30] Transgene
(A) Representative K1 current recorded from
inside-out membrane patches from pancre-
atic b cells isolated from adult Kir6.2[DN2-
30] transgenic mice or control littermate. KATP
currents were measured at 250 mV in Kint
solution, and patches were exposed to dif-
fering [ATP] as shown.
(B) Steady-state dependence of membrane
current on [ATP] (relative to current in zero
ATP) for channels from control and transgenic
mice. Data points represent the mean 6 SEM
of all patches (n 5 15). The data were fitted
using a Hill equation (see Figure 1), with H
(Hill coefficient) free to vary. Mean values
were Ki 5 12 mM (control) and 43 mM
(Kir6.2[DN2-30] transgenic) and H 5 1.2 (con-
trol) and 0.8 (transgenic). Dashed lines show
behavior of wild-type Kir6.2 1SUR1, and
Kir6.2[DN2-30]1SUR1 channels in COSm6
cells (from Figure 1).
(C) Calculated Ki for ATP inhibition from indi-
vidual b cell membrane patches like those
shown in (A) for both control (open circle, n 5
15 patches from two mice) and transgenic
mice (closed circle, n 5 15 patches from two
mice), and Kir6.2[AAA] transgenic mice. In the
latter, only 6 of 23 patches showed any mea-
surable activity. The data were fit using the
Hill equation, mean 6 SEM is shown; *, P ,
0.02; unpaired students t-test.
(D) Averaged maximal ATP-sensitive K1 currents from control and transgenic membrane patches. Micropipette size for each patch was
assumed similar and corresponded to pipette resistance of » 1 MV. For Kir6.2[AAA] patches, all 23 membrane patches were included.
for the specific functional mutations and is expressed argue strongly that depressed insulin secretory re-
sponse, due to altered KATP channel function, rather thanat least as strongly as the Kir6.2[DN2-30] transgene,
causes no such animal phenotype. Together, these data gross morphological changes in transgenic islets, are
Figure 5. Histological Analysis of Pancreatic
Islets from Kir6.2[DN2-30] and Control Mice
Representative immunostaining of pancre-
atic sections from 3 day transgenic and con-
trol littermate mice (line A) with anti-insulin
antibody as described in the Experimental
Procedures. Colored precipitate identifies the
insulin-positive b cell population. Pancreatic
sections were counterstained with hematox-
ylin. Black boxes correspond to regions mag-
nified to generate (B) and (D). Magnification,
(A) and (C), 3 10; (B) and (D), 340.
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Figure 6. Identification of a and b Cell Popu-
lations in Islets from Kir6.2[DN2-30] Trans-
genic and Control Mice by Immunofluores-
cence
Immunofluorescence of consecutive serial
sections of islet cells from 1 day transgenic, 3
day transgenic (line A), and control littermate
mice with anti-insulin (A, C, and E) and anti-
glucagon antibodies (B, D, and F). Consistent
with normal islet morphology, insulin con-
taining b cells from a 1 day transgenic mouse
form the core of the islet, whereas glucagon-
positive a cells are found in the periphery.
For visualization purposes, immunofluores-
cent signal obtained with anti-glucagon anti-
body was printed from a green fluorescence
to red fluorescence. Magnification, 340.
responsible for profound hyperglycemia and hypoinsu- sensitivity is a critical determinant of the coupling be-
tween glucose and insulin secretion. Site-directed muta-linemia at the earliest stages.
tional analyses (Tucker et al., 1997, 1998; Drain et al.,
1998; Babenko et al., 1999; Koster et al. 1999a; Proks
Implications of These Results et al., 1999) show that mutations throughout the Kir6.2
Although there is strong evidence that KATP channel ac- structure can cause similar, and even far more signifi-
tivity is critical for control of insulin secretion in pancre- cant, reductions of ATP sensitivity. Although prior stud-
atic b cells (Misler et al., 1992), recent studies cloud the ies of diabetic patients have not demonstrated signifi-
issue and draw attention to non-KATP-dependent mecha- cant linkage between diabetes and Kir6.2 (Hani et al.,
nisms (Aizawa et al., 1998). We have tested a critical 1998), it remains possible that untested diabetic popula-
prediction of the KATP channel paradigm: namely, that tions suffer from mutations in the Kir6.2 gene. In addi-
channels with reduced sensitivity to [ATP] should cause tion, it has recently been made clear that the intrinsic
diabetes as a result of reduced insulin secretion. The sensitivity of KATP channels to ATP is not a fixed parame-
data indicate a dramatic effect of reduced sensitivity ter. Membrane lipids, including fatty acyl CoAs (Bran-
to nucleotide inhibition on control of insulin secretion, strom et al., 1997, 1998; Gribble et al., 1998) and phos-
demonstrating a crucial requirement for appropriate phatidylinositol-4,5-bisphosphate (PIP2) (Hilgemann and
control of KATP channel activity in normal regulation of Ball, 1996; Fan and Makielski, 1997; Baukrowitz et al.,
insulin secretion. Surprisingly, the severe diabetic phe- 1998; Shyng and Nichols, 1998), can modulate channel
notype exhibited by Kir6.2[DN2-30] transgenic mice re- activity, and dramatically reduce ATP sensitivity of the
sults from a comparatively small reduction in intrinsic channel. Elevation of these lipids within the b cell mem-
brane would be predicted to reduce the sensitivity ofATP sensitivity (z7-fold) and suggests that channel ATP
Cell
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with hydrogen peroxide and the chromagen diaminobenzidineinsulin release to glucose levels, and recapitulate the
([DAB]; Sigma) for 4 min at 258C. For immunofluorescence, pancre-phenotype we describe. In this regard, it has recently
atic sections were incubated overnight at 48C with a guinea pig anti-been demonstrated that leptin activates KATP channels insulin primary antibody (1:250; Linco Research) or a guinea pig
in insulin-secreting cells (Harvey et al., 1997; Kieffer et anti-glucagon primary antibody (1:500; Linco Research). Primary
al., 1997) and that a cellular consequence of leptin re- antibodies were detected by incubating for 1.5 hr at 258C with an
anti-guinea pig secondary antibody conjugated with the Alexa 488ceptor stimulation is upregulation of PI kinases (Kellerer
fluorescent dye (Molecular Probes).et al., 1997) and elevation of membrane PIP2. The fasci-
nating possibility that leptin, or other agents that lead
Patch-Clamp Measurementsto reduced ATP sensitivity of KATP channels, may be a
Patch-clamp experiments were performed as previously describedcause of insulin secretory deficits such as can be seen
(Koster et al., 1999a). The standard bath (intracellular) and pipettein Type 2 diabetes should perhaps be considered.
(extracellular) solution used in these experiments (K-INT) had the
following composition: 140 mM KCl, 10 mM K-HEPES, and 1 mM
Experimental Procedures K-EGTA (pH 7.3). All currents were measured at a membrane poten-
tial of 250 mV (pipette voltage 5 150 mV). Inward currents at this
Construction of Mutant Kir6.2 Constructs voltage are shown as upward deflections. Data were normally fil-
Kir6.2 [DN2-30], Kir6.2[DN2-30,K185Q], and Kir6.2[AAA] constructs tered at 0.5±3 kHz, and signals were digitized at 22 kHz (Neurocorder
(see Figure 1 for details) containing green fluorescence protein tags [Neurodata]) and stored on videotape. Experiments were replayed
at the C termini were prepared by deletional mutagenesis using onto a chart recorder, or digitized into a microcomputer using Axo-
polymerase chain reaction (PCR). The resulting PCR products were tape software (Axon, Inc.). Off-line analysis was performed using
subcloned into pCMV6b, and nucleotide sequences were verified Microsoft Excel programs. Wherever possible, data are presented
by fluorescence-based cycle sequencing using AmpliTaq DNA poly- as mean 6 SEM (standard error of the mean).
merase. To confirm functional expression, mutant Kir6.2 subunits
were coexpressed with SUR1 in COSm6 cells using transient trans- Measurements of Blood Glucose, Insulin,
fection, as described previously (Koster et al., 1999a). and D-3-hydroxybutyrate Levels
Whole blood was assayed for blood glucose using the glucose
Generation of Transgenic Mice dehydrogenase-based enzymatic assay and quantitated using the
Mutant Kir6.2 DNA constructs were excised as EcoRI/EcoRI frag- Hemocue glucose meter (Hemocue, Inc.). Blood insulin levels were
ments and inserted downstream of the rat insulin I promoter in the assayed on 5 ml of mouse serum using the Rat Insulin ELISA Kit
transgenic plasmid pRIP I (Dandoy-Dron et al., 1991) (pRIP I was a with a mouse insulin standard (Crystal Chemical). D-3-hydroxybutyr-
kind gift of Dr. Paul N. Epstein). The expression cassettes were ate was measured as previously described (Marshall and Mueckler,
excised by enzyme digestion, purified, and microinjected into fertil- 1994).
ized eggs of C57Bl6 3 CBA mice according to standard technique
(Hogan et al., 1994), either at the NICHD Transgenic Mouse Develop-
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bama, Birmingham, or in the Washington University Neuroscience
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ported by National Institutes of Health grants DK55282 (C. G. N.),Kir6.2[AAA] and five Kir6.2[DN2-30] transgenic founders were identi-
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We are grateful for additional support from a grant from the Hardisonin all experiments unless otherwise noted.
Family Foundation (B. A. M.), a Career Development Award from
the American Diabetes Association (B. A. M.), National Institutes of
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[1 mg/ml], 5.6 mM D-Glucose, and collagenase [2 mg/ml; pH 7.4]).
Received November 11, 1999; revised February 2, 2000.Collagenase Type II was obtained from Worthington Biochemical
Corporation. Pancreata were digested for 10 min at 248C by hand
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